Crayon Capital

Crayon Capital episode explains Ozempic's origins, mechanism, and market impact

19 min Listen to the original
PharmaceuticalsBiotechWeight LossGLP1Novo NordiskClinical TrialsSupply ChainRegulatory

Summary

The episode details the discovery of GLP1 analogs in Gila monster venom and Novo Nordisk's decades-long development of a stable weekly drug. It covers the 2017 FDA approval for type 2 diabetes, the subsequent observation of significant weight loss, and the 2021 approval of Wegovy for obesity. Speakers highlight clinical trial results showing 15% average weight loss, supply shortages, and the rise of a dangerous gray market. The discussion also addresses side effects, the necessity of long-term use, and future applications for addiction and neurodegenerative diseases.

Key takeaways

  1. 1
    Side effects include nausea, vomiting, and muscle loss, with weight regain occurring if the drug is discontinued.

    Unidentified speaker (speaker_0) · 16:58

Episode sections

  1. 0:01 – 2:52

    Introduction and Sponsor Reads

    Episode begins with sponsor reads and introduces the topic of Ozempic and weight loss difficulties.

  2. 2:52 – 4:57

    Origins: Gila Monster Venom and GLP1

    Dr. John Eng's discovery of GLP1-like compounds in Gila monster venom and their role in satiety.

  3. 4:57 – 9:57

    Novo Nordisk's Development of a Weekly Drug

    Decades of R&D, 216 failed attempts, and the solution of attaching a fatty acid chain to stabilize the drug.

  4. 9:57 – 11:14

    FDA Approval and Unexpected Weight Loss

    2017 approval for type 2 diabetes and the observation of significant weight loss in patients.

  5. 11:14 – 14:49

    Clinical Trials and Wegovy Approval

    Trials showing 15% average weight loss and the 2021 FDA approval of Wegovy for obesity.

  6. 14:49 – 16:58

    Supply Shortages and Gray Market Risks

    2022 FDA shortage listings, supply constraints, and the rise of dangerous counterfeit products.

  7. 16:58 – 17:30

    Side Effects and the 'Subscription' Model

    Discussion of nausea, muscle loss, and the necessity of long-term use to maintain results.

  8. 17:30 – 19:26

    Next-Generation Drugs and Future Applications

    Development of drugs preserving muscle, monthly dosing, and applications for addiction and neurodegenerative diseases.

Claims worth verifying

More than a billion adults are now classified as obese, a number that has tripled since 1975.

Unidentified speaker (speaker_0) ·2:07

How to verify: CDC National Health and Nutrition Examination Survey (NHANES) data on obesity prevalence trends from 1975 to present. For recent events, verify 2026-08-09 through 2026-11-09. Use another period only when the speaker explicitly names it.

Dr. John Eng was an endocrinologist at a VA hospital in the Bronx who studied Gila monster venom.

Unidentified speaker (speaker_0) ·2:57

How to verify: PubMed or NIH publications by John Eng on exendin-4/GLP-1 analogs from Gila monster venom. For recent events, verify 2026-08-09 through 2026-11-09. Use another period only when the speaker explicitly names it.

Novo Nordisk is a Danish company that has spent 50 years as the backbone of diabetic care.

Unidentified speaker (speaker_0) ·4:57

How to verify: Novo Nordisk corporate history section on their investor relations website or Wikipedia entry for Novo Nordisk. For recent events, verify 2026-08-09 through 2026-11-09. Use another period only when the speaker explicitly names it.

Novo Nordisk made 216 attempts to create a stable GLP1 drug before succeeding.

Unidentified speaker (speaker_0) ·9:39

How to verify: Novo Nordisk annual reports or press releases detailing the development timeline of semaglutide. For recent events, verify 2026-08-09 through 2026-11-09. Use another period only when the speaker explicitly names it.

The FDA approved Ozempic for type 2 diabetes in 2017.

Unidentified speaker (UNKNOWN) ·9:57

How to verify: FDA Drug Approval Database search for 'semaglutide' or 'Ozempic' approval date. For recent events, verify 2026-08-09 through 2026-11-09. Use another period only when the speaker explicitly names it.

Clinical trials showed patients lost an average of 15% of their body weight.

Unidentified speaker (speaker_0) ·11:21

How to verify: New England Journal of Medicine publication of the STEP clinical trial results for semaglutide. For recent events, verify 2026-08-09 through 2026-11-09. Use another period only when the speaker explicitly names it.

Previous FDA-approved weight loss drugs usually delivered around 5 to 8% weight loss on average.

Unidentified speaker (speaker_0) ·11:30

How to verify: FDA approval labels for prior weight loss drugs (e.g., Orlistat, Liraglutide) and associated clinical trial data. For recent events, verify 2026-08-09 through 2026-11-09. Use another period only when the speaker explicitly names it.

The FDA approved Wegovy for obesity in 2021.

Unidentified speaker (UNKNOWN) ·14:01

How to verify: FDA Drug Approval Database search for 'Wegovy' or 'semaglutide obesity' approval date. For recent events, verify 2026-08-09 through 2026-11-09. Use another period only when the speaker explicitly names it.

Ozempic generated $26 billion in revenue by 2024.

Unidentified speaker (speaker_0) ·14:34

How to verify: Novo Nordisk Q3 2024 or Annual Report 2024 financial statements. For recent events, verify 2026-08-09 through 2026-11-09. Use another period only when the speaker explicitly names it.

The FDA placed Ozempic and Wegovy on its shortage list in 2022.

Unidentified speaker (UNKNOWN) ·14:52

How to verify: FDA Drug Shortages List archive for 2026 entries for semaglutide products. For recent events, verify 2026-08-09 through 2026-11-09. Use another period only when the speaker explicitly names it.

Do your own research

  • Verify Novo Nordisk's R&D pipeline disclosures in their annual reports for next-generation drug timelines.
  • Check FDA shortage lists and import alerts for gray market GLP1 products.
  • Review clinical trial data for muscle preservation claims in upcoming GLP1 agonists.
  • Assess Novo Nordisk's supply chain capacity and manufacturing constraints reported in earnings calls.
  • Investigate regulatory actions against counterfeit GLP1 distributors in major markets.
  • Compare efficacy and side effect profiles of Wegovy vs. Ozempic in peer-reviewed journals.
  • Monitor competitor developments from Eli Lilly and other pharma companies in the GLP1 space.
  • Evaluate the long-term economic impact of obesity treatment on healthcare systems and insurance models.
Full transcriptexpand
0:01
Unidentified speaker (speaker_0): Legendary has arrived in Alberta with BetMGM Sportsbook. Sign up to unlock access to hundreds of pregame and live betting options for all your favorite sports, including hockey, baseball, soccer, and much more. Have a hunt your favorite player is gonna have a great game? Lock in your picks and watch the action unfold. You can make your picks
0:21
Unidentified speaker (speaker_0): on your favorite team too. And every time you play, you can enjoy instant deposit options and fast. withdrawals. BetMGM Sportsbook is available in Alberta. Download the app and experience Vegas thrills in the palm of your hand. See BetMGM.com for terms. 18 Plus Alberta only, please play responsibly, subject to
0:41
Unidentified speaker (speaker_0): eligibility requirements. If
0:42
Unidentified speaker (speaker_1): gambling is affecting your mental health or well-being, 211 Alberta is here to help. Call or text 211 or visit ab.211.ca. BetMGM operates pursuant to an operating agreement with the Alberta iGaming Corporation. Standard message and data rates may apply.
0:59
Unidentified speaker (UNKNOWN): So
0:59
Unidentified speaker (speaker_2): your decaf oat milk, extra but not piping hot, four pumps of caramel, no sugar, small latte, and a large cup. That will be 10 minutes.
1:06
Unidentified speaker (speaker_3): No worries. I'm having fun on Playo.
1:09
Unidentified speaker (UNKNOWN): And
1:09
Unidentified speaker (speaker_3): I keep it fun with all the latest slot and live casino games. Plus, I get instant payouts with no minimum withdrawals. Oh, and no wagering requirements ever.
1:18
Unidentified speaker (UNKNOWN): Here's
1:18
Unidentified speaker (speaker_2): your decaf oat milk extra, but not piping hot.
1:21
Unidentified speaker (speaker_3): Ah, thanks. Playtime's over.
1:23
Unidentified speaker (UNKNOWN): Mmm,
1:23
Unidentified speaker (speaker_3): lovely.
1:24
Unidentified speaker (speaker_1): Feels fun.
1:25
Unidentified speaker (UNKNOWN): Play Oat Joe.
1:26
Unidentified speaker (speaker_3): 18 plus Alberta only. Please play responsibly. Full-term supply.
1:30
Unidentified speaker (UNKNOWN): It's
1:30
Unidentified speaker (speaker_1): the family and friends event at Shoppers Drug Mart. Get 20% off almost all regular priced merchandise. Monday, November 9th to Wednesday, November. 11th. Open your PC Optimum app to get your coupon.
1:45
Unidentified speaker (UNKNOWN): This
1:45
Unidentified speaker (speaker_0): is Ozempic,
1:47
Unidentified speaker (UNKNOWN): the
1:47
Unidentified speaker (speaker_0): drug that can make people lose this much weight with just one injection a week.
1:51
Unidentified speaker (UNKNOWN): But
1:51
Unidentified speaker (speaker_0): how does it actually work?
1:53
Unidentified speaker (UNKNOWN): Is
1:53
Unidentified speaker (speaker_0): it truly safe?
1:55
Unidentified speaker (UNKNOWN): And
1:55
Unidentified speaker (speaker_0): what happens when people stop taking
1:57
Unidentified speaker (UNKNOWN): it? To
1:58
Unidentified speaker (speaker_0): answer these questions, we first need to understand why losing weight is so difficult.
2:07
Unidentified speaker (speaker_0): The world has a fat problem, a massive global decades-long problem. More than a billion adults are now classified as obese, a number that has tripled since 1975. So the solution should be simple, right? Eat less, move more, problem solved? No, because the moment you start eating
2:27
Unidentified speaker (speaker_0): less, your body says, We are under attack. Release the hunger.
2:32
Unidentified speaker (UNKNOWN): Your
2:32
Unidentified speaker (speaker_0): metabolism slows down. Your body starts treating every calorie like it's the last helicopter out of Saigon. Which is why so many people lose weight and then gain it all back. For decades, scientists knew the body was fighting back. They just couldn't figure out how to turn that signal off. Then the answer came from the
2:52
Unidentified speaker (speaker_0): last place anyone expected. A lizard.
2:57
Unidentified speaker (speaker_0): Introducing Dr. John Eng.
3:00
Unidentified speaker (speaker_0): Eng was an endocrinologist, a doctor who treats hormone-related problems in the body at a VA hospital in the Bronx with a very unusual interest. Venom. More specifically, the venom of the Gila monster.
3:13
Unidentified speaker (UNKNOWN): A
3:14
Unidentified speaker (speaker_0): large, small slow, deeply unfortunate-looking lizard from the American Southwest that looks like it was assembled from leftover parts. John.
3:23
Unidentified speaker (speaker_0): What are you doing?
3:25
Unidentified speaker (UNKNOWN): This
3:26
Unidentified speaker (speaker_0): thing barely eats, sometimes only a few times a year. And yet, somehow, its body stays stable. Maybe that is just what it does. Ain't no way. Something in that saliva is keeping it alive.
3:39
Unidentified speaker (UNKNOWN): So
3:40
Unidentified speaker (speaker_0): Eng studies the lizard's venom, and inside it, he finds something remarkable. A compound that behaves a lot like a human hormone called GLP1.
3:51
Unidentified speaker (UNKNOWN): Now,
3:52
Unidentified speaker (speaker_0): GLP1 is basically the body's meal signal. You eat. Your gut sends a message to your brain. Food arrived. You can stop eating now.
4:01
Unidentified speaker (UNKNOWN): Then
4:02
Unidentified speaker (speaker_0): it sends a another message to your pancreas. Sugar incoming. Release insulin. When that signal works properly, the body handles food without much drama. When it does not, everything starts getting messier. Appetite, insulin response, blood sugar, weight.
4:19
Unidentified speaker (UNKNOWN): The
4:19
Unidentified speaker (speaker_0): whole system begins slipping out of balance. And Eng realizes something huge. What if you could replace that failing signal?
4:27
Unidentified speaker (UNKNOWN): That
4:27
Unidentified speaker (speaker_0): idea eventually leads to the first GLP1 drug. For the first time, medicine is not just treating the consequences of metabolic disease, it is trying to restore one of the signals behind
4:38
Unidentified speaker (UNKNOWN): it. But
4:38
Unidentified speaker (speaker_0): there is one problem
4:40
Unidentified speaker (UNKNOWN): the
4:41
Unidentified speaker (speaker_0): drug is clunky. Patients need to inject it twice a day. The effect fades quickly, so most of the world shrugs and moves on. Except for one company watching from demo. Denmark. They look at the same drug everyone else dismisses and see something different.
4:57
Unidentified speaker (speaker_0): Introducing Novo Nordisk.
5:00
Unidentified speaker (UNKNOWN): They
5:00
Unidentified speaker (speaker_0): are a Danish company that has spent 50 years as the backbone of diabetic care. Insulin is their main solution. But it has limits. Insulin helps manage blood sugar and keep patients alive. Yet it does not fix the deeper signaling problem under. underneath where GLP1 might. So Novo sets itself a brutal goal. Let's make it last for
5:20
Unidentified speaker (speaker_0): a week. That is the target. The molecule dissolves in minutes, two minutes. How do you build a weekly drug out of something that dissolves quickly? That is the job. And this is where the nightmare begins.
5:33
Unidentified speaker (UNKNOWN): The
5:34
Unidentified speaker (speaker_0): moment natural GLP1 enters the bloodstream, the body breaks it down almost immediately.
5:39
Unidentified speaker (UNKNOWN): So
5:40
Unidentified speaker (speaker_0): they change the molecular structure. Twaking it for stability, it loses power.
5:47
Unidentified speaker (speaker_0): Legendary has arrived in Alberta
5:49
Unidentified speaker (UNKNOWN): with BetMGM Sportsbook. Sign up
5:51
Unidentified speaker (speaker_0): to unlock
5:52
Unidentified speaker (UNKNOWN): access to hundreds
5:53
Unidentified speaker (speaker_3): of pregame and live betting options for all your favorite sports, including hockey, baseball, soccer, and much more. Have a hunt your favorite player is gonna have a great game.
6:03
Unidentified speaker (speaker_3): Lock in your picks and watch the action unfold. You can make your picks on your favorite team too. And every time you play, you can enjoy instant deposit options and fast withdrawals. BetMGM Sportsbook is available in Alberta. Download the app and experience Vegas thrills in the palm of your hand. See BetMGM.com for terms.
6:23
Unidentified speaker (speaker_3): 18 Plus Alberta only, please play responsibly. Subject to LG. eligibility requirements.
6:28
Unidentified speaker (UNKNOWN): If
6:28
Unidentified speaker (speaker_1): gambling is affecting your mental health or well being, 211 Alberta is here to help. Call or text 211 or visit ab.211.ca. BetMGM operates pursuant to an operating agreement with the Alberta Eye Gaming Corporation. Standard message and data rates may apply.
6:45
Unidentified speaker (UNKNOWN): So
6:45
Unidentified speaker (speaker_2): your decaf oat milk, extra but not piping hot, four pumps of caramel, no sugar, small latte, and a large. cup. That will be 10 minutes.
6:52
Unidentified speaker (speaker_3): No worries. I'm having fun on Play Ojo.
6:55
Unidentified speaker (UNKNOWN): And
6:55
Unidentified speaker (speaker_3): I keep it fun with all the latest slot and live casino games. Plus, I get instant payouts with no minimum withdrawals. Oh, and no wagering requirements ever.
7:04
Unidentified speaker (speaker_2): Here's your decaf oat milk extra but not piping hot.
7:06
Unidentified speaker (speaker_3): Ah, thanks. Playtime's over. Mmm, lovely. Feel
7:10
Unidentified speaker (UNKNOWN): the fun, play ojo.
7:12
Unidentified speaker (speaker_3): 18 plus Alberta only. Please play responsibly. Full terms. term supply.
7:16
Unidentified speaker (speaker_2): In 2002, Ryan Wedding was an Olympic snowboarder at the top of his game.
7:21
Unidentified speaker (speaker_0): Ryan's style is really gunned and go.
7:24
Unidentified speaker (speaker_2): And in less than a minute, it slipped away. But he continued to chase the high.
7:28
Unidentified speaker (speaker_0): Ryan James Wedding. He controls one of the most violent drug trafficking organizations in this world. I'm
7:36
Unidentified speaker (speaker_2): Michelle Shepherd, and from CBC Podcasts and the Toronto Star, The Most Wanted Olympian.
7:41
Unidentified speaker (speaker_0): The Most Wanted
7:42
Unidentified speaker (speaker_3): Olympian. Available now on Spotify.
7:45
Unidentified speaker (speaker_0): Making it more powerful, the body destroys it faster. Again and again and again. 216 versions. None good enough. But now it's a good enough time for a quick ad break.
7:58
Unidentified speaker (UNKNOWN): You
7:59
Unidentified speaker (speaker_0): know what's weird? I'll spend three hours researching whether a $20 gag. gadget is worth buying. But the moment I need to book a doctor's appointment, suddenly my brain goes, eh, tomorrow. Because then you have to call, wait on hold, play phone tag, and by the time someone finally answers, the next appointment is sometime after the heat
8:19
Unidentified speaker (speaker_0): death of the universe. That's why I've started using ZocDoc. It lets you search and compare local in-network doctors, read reviews from real patients. check actual appointment availability, and book online in just a few clicks. Appointments are often available within 24 to 72 hours, sometimes even the same day. And it's completely free to
8:38
Unidentified speaker (speaker_0): use. So if you've been putting off making that appointment like I used to, click the link in the description or head to ZocDoc.com/slash Crayon Capital. Seriously, it's a small click that makes taking care of your health a whole lot easier. easier.
8:54
Unidentified speaker (speaker_0): Okay, back to Novo.
8:57
Unidentified speaker (speaker_0): The costs keep growing and the confidence shrinking.
9:00
Unidentified speaker (UNKNOWN): The
9:01
Unidentified speaker (speaker_0): problem is starting to look unsolvable? But then,
9:05
Unidentified speaker (UNKNOWN): what
9:05
Unidentified speaker (speaker_0): if we attach a fatty acid chain to it?
9:08
Unidentified speaker (UNKNOWN): A
9:08
Unidentified speaker (speaker_0): fatty acid? Why? Okay, think of the bloodstream like a nightclub. The body's enzymes are the bouncers. Anything foreign gets spotted and thrown
9:17
Unidentified speaker (UNKNOWN): out?
9:18
Unidentified speaker (speaker_0): Our drug? Kicked out in minutes.
9:21
Unidentified speaker (UNKNOWN): But
9:21
Unidentified speaker (speaker_0): albumin is a protein that naturally lives in the blood. The VIP who's never questioned?
9:27
Unidentified speaker (UNKNOWN): And
9:28
Unidentified speaker (speaker_0): the only thing that gets albumin's attention? Fatty acids. It's basically albumin's magnet. So if we attach a fatty acid to our drug, albumin pulls it in like a plus one.
9:39
Unidentified speaker (speaker_0): Suddenly it's not a stranger anymore. It's rolling in with the VIP. Bouncers wave it through. It stays in the system for a week. At last, on the 217 attempts, they have it. A lab-engineered version of the body's own signal, built to last seven days instead of minutes.
9:57
Unidentified speaker (UNKNOWN): In
9:57
Unidentified speaker (speaker_0): 2017, the FDA approved it for type 2 diabetes.
10:01
Unidentified speaker (UNKNOWN): And
10:02
Unidentified speaker (speaker_0): they name it. Ozempic.
10:04
Unidentified speaker (UNKNOWN): It is
10:05
Unidentified speaker (speaker_0): a quiet launch, no headlines, just another diabetes drug entering a crowded market. But doctors start noticing something strange.
10:14
Unidentified speaker (UNKNOWN): Did
10:14
Unidentified speaker (speaker_0): you change these patients' diets? Tell them to exercise or anything?
10:18
Unidentified speaker (UNKNOWN): Hmm,
10:19
Unidentified speaker (speaker_0): I don't think I did. Why is something wrong? No, it's just they lost weight, like all of them.
10:30
Unidentified speaker (UNKNOWN): For
10:30
Unidentified speaker (speaker_0): most companies, this would be the dream.
10:33
Unidentified speaker (UNKNOWN): A
10:33
Unidentified speaker (speaker_0): diabetes drug that also makes people lose weight? That is a jackpot, not a side effect. But inside Novo, nobody is celebrating too loudly yet, because weight loss drugs had a history. A very ugly one. The results were disappointing, dangerous or both.
10:50
Unidentified speaker (UNKNOWN): Fen
10:50
Unidentified speaker (speaker_0): Fen. pulled in 1997? Meridian pulled in 2010?
10:56
Unidentified speaker (UNKNOWN): By
10:56
Unidentified speaker (speaker_0): the 2010s, much of medicine had reached an uncomfortable conclusion. Maybe obesity was too complicated for a drug to solve.
11:04
Unidentified speaker (UNKNOWN): But
11:04
Unidentified speaker (speaker_0): Novo doesn't flinch. They launch a major clinical trial to answer one question: Can this drug cause major weight loss in people who do not even have diabetes?
11:14
Unidentified speaker (speaker_0): Hi, I'm calling from Novo. I just wanted to check if the trial data has been reviewed yet. Yes.
11:20
Unidentified speaker (UNKNOWN): We
11:21
Unidentified speaker (speaker_0): finished going through it this morning? Patients lost an average of 15% of their body weight. Some were closer to 20. Sorry, what? 15%?
11:30
Unidentified speaker (speaker_0): Average. Across the trial. Before this, the best FDA-approved weight loss drugs usually delivered around 5 to 5-8% 8%. weight loss on average. That was considered strong. This is not a slightly better obesity drug.
11:47
Unidentified speaker (speaker_3): Legendary has arrived in Alberta with BetMGM Sportsbook. Sign up to unlock access to hundreds of pregame and live betting options for all your favorite sports, including hockey, baseball, soccer, and much more. Have a hunt your favorite player is gonna have a great game. Lock in your picks and watch the action unfold. You can make your picks on
12:07
Unidentified speaker (speaker_3): your favorite team too. And every time you play, you can enjoy instant deposit options and fast withdrawals. BetMGM Sportsbook is available in Alberta. Download the app and experience Vegas thrills in the palm of your hand. See BetMGM.com for terms. 18 Plus Alberta only, please play responsibly. Subject to eligibility.
12:27
Unidentified speaker (speaker_3): requirements.
12:28
Unidentified speaker (UNKNOWN): If
12:28
Unidentified speaker (speaker_1): gambling is affecting your mental health or well-being, 211 Alberta is here to help. Call or text 211 or visit ab.211.ca. BetMGM operates pursuant to an operating agreement with the Alberta Eye Gaming Corporation. Standard message and data rates may apply.
12:45
Unidentified speaker (UNKNOWN): So
12:45
Unidentified speaker (speaker_2): your decaf oat milk, extra but not piping hot, four pumps of caramel, no sugar, small latte, and a large cup. That will be 10 minutes.
12:52
Unidentified speaker (speaker_3): No worries. I'm having fun on Play Ojo.
12:55
Unidentified speaker (UNKNOWN): And
12:55
Unidentified speaker (speaker_3): I keep it fun with all the latest slot and live casino games. Plus I get instant payouts with no minimum withdrawals. Oh, and no wagering requirements ever.
13:04
Unidentified speaker (speaker_2): Here's your decaf oat milk extra but not piping hot.
13:06
Unidentified speaker (speaker_3): Ah, thanks. Playtime's over.
13:08
Unidentified speaker (UNKNOWN): Mmm,
13:09
Unidentified speaker (speaker_3): lovely. Feel
13:10
Unidentified speaker (UNKNOWN): the fun, play O ojo. Joe.
13:12
Unidentified speaker (speaker_3): 18 plus Alberta only. Please play responsibly, full term supply.
13:15
Unidentified speaker (speaker_2): In 2002, Ryan Wedding was an Olympic snowboarder at the top of his game. Ryan's
13:21
Unidentified speaker (UNKNOWN): style is really gunned and go.
13:23
Unidentified speaker (speaker_2): And in less than a minute, it slipped away. But he continued to chase the high.
13:30
Unidentified speaker (speaker_1): He controls one of the most violent drug trafficking organizations in this world. I'm
13:36
Unidentified speaker (speaker_2): Michelle Shepherd, and from CBC Podcasts and the Toronto. Star, the Most Wanted Olympian.
13:41
Unidentified speaker (speaker_3): The Most Wanted Olympian, available now on Spotify.
13:45
Unidentified speaker (speaker_0): This isn't a completely different league. A weekly injection was now producing numbers people used to associate with surgery.
13:51
Unidentified speaker (UNKNOWN): So
13:52
Unidentified speaker (speaker_0): researchers and regulators check the data again and again. The methodology holds, the results hold.
13:59
Unidentified speaker (UNKNOWN): The
13:59
Unidentified speaker (speaker_0): weight loss is real.
14:01
Unidentified speaker (UNKNOWN): So
14:01
Unidentified speaker (speaker_0): by 2021, the FDA approved a higher dose version specifically for obesity, Wegovie. And just like that, the drug splits into two identities: Ozempic for diabetes, the stronger dose for weight loss. That is when the story leaves medicine and enters culture. Doctors start getting flooded with questions,
14:21
Unidentified speaker (speaker_0): patients start asking for it by name because suddenly celebrities are looking smaller. Influencers are whispering about it, and search traffic is exploding.
14:34
Unidentified speaker (speaker_0): Ozempic goes viral. Demand surges, sales explode, where by 2024 the drugs generated $26 billion in revenue. Novonordisk becomes one of the biggest pharmaceutical stories on earth. But there is one problem:
14:49
Unidentified speaker (UNKNOWN): they
14:49
Unidentified speaker (speaker_0): cannot make enough.
14:52
Unidentified speaker (UNKNOWN): In
14:52
Unidentified speaker (speaker_0): 2022, the FDA placed Ozempic and Wegovie on its shortage list.
14:57
Unidentified speaker (UNKNOWN): And
14:57
Unidentified speaker (speaker_0): this is where the story gets ugly. Good afternoon. Welcome to Crayon Pharmacy? Picking up a prescription?
15:04
Unidentified speaker (UNKNOWN): Yes,
15:04
Unidentified speaker (speaker_0): Ozempic. I see it here. Just so you know, your insurance didn't cover it, so this would be out of pocket today. How much? Total is $1,200.
15:15
Unidentified speaker (speaker_0): Fine.
15:19
Unidentified speaker (speaker_0): Sorry, you have Ozempik? I'm here for another prescription. But I've been trying to get a refill for weeks. I see your refill request. Your insurance covered order is still pending. We're waiting on allocated stock for covered prescriptions.
15:32
Unidentified speaker (UNKNOWN): But
15:33
Unidentified speaker (speaker_0): there's one right there. This one has already been processed as a cash pay prescription, so if I can pay cash? I can get it today.
15:42
Unidentified speaker (UNKNOWN): I
15:42
Unidentified speaker (speaker_0): have type 2 diabetes. I've been on this for two years. I really need this. Is there a problem?
15:50
Unidentified speaker (speaker_0): You're all set. Thank you for waiting. Your medication and receipt are in the bag. Have a wonderful
15:56
Unidentified speaker (UNKNOWN): day.
16:02
Unidentified speaker (speaker_0): Regarding your situation, we can fill the temporary medication your doctor sent in. You've got to be kidding
16:08
Unidentified speaker (UNKNOWN): me. I'm
16:09
Unidentified speaker (speaker_0): sorry for the inconvenience, but until your insurance-covered refill clears, there's nothing I can release today except the temporary medication.
16:18
Unidentified speaker (speaker_0): And that is the dangerous part.
16:20
Unidentified speaker (UNKNOWN): If
16:20
Unidentified speaker (speaker_0): the official system will not give people the drug, someone else in the gray market will. Clinics offering the alternatives. at a fraction of the market price. $200 a month instead of $1,200, no wait list, no insurance battle, a quick online form, and a vial arrive at your door. It sounded perfect for desperate patients. Until it
16:40
Unidentified speaker (speaker_0): wasn't.
16:41
Unidentified speaker (UNKNOWN): By
16:41
Unidentified speaker (speaker_0): 2023, PhagoZimpic has entered the American drug supply chain, manufactured to look real, distributed through channels that bypass safety checks, sold into a market. desperate for the miracle. Some patients received the wrong dose or the wrong substance, leading to some being hospitalized.
16:58
Unidentified speaker (UNKNOWN): But
16:58
Unidentified speaker (speaker_0): even the real drug wasn't perfect. Nausea, vomiting, sometimes bad enough that patients quit in the first month. Doctors started noticing muscle loss alongside the fat.
17:09
Unidentified speaker (UNKNOWN): And
17:09
Unidentified speaker (speaker_0): the worst part? I stopped taking it six months ago. I've gained almost everything back. That's not uncommon.
17:17
Unidentified speaker (UNKNOWN): So
17:18
Unidentified speaker (speaker_0): is this a cure or a subscription?
17:20
Unidentified speaker (UNKNOWN): The
17:21
Unidentified speaker (speaker_0): drug didn't cure anything. It managed it. Stopped paying.
17:25
Unidentified speaker (UNKNOWN): The
17:25
Unidentified speaker (speaker_0): hunger comes back. The body remembers.
17:28
Unidentified speaker (UNKNOWN): But
17:29
Unidentified speaker (speaker_0): we had been here before.
17:30
Unidentified speaker (UNKNOWN): Novo
17:31
Unidentified speaker (speaker_0): Nordisk failed 216 attempts. Every dead end eventually wasn't. So the scientists went back to work.
17:38
Unidentified speaker (UNKNOWN): Next
17:38
Unidentified speaker (speaker_0): generation drugs already in trials, preserving muscle, lasting a month instead of a week, showing signals in alcohol cravings, opioid addiction, even brain disease. What started in a lizard's venom was turning out to be something much larger.
17:53
Unidentified speaker (UNKNOWN): By
17:54
Unidentified speaker (speaker_0): 2025, the chaos had settled, supply caught up, the gray market collapsed, and quietly, without anyone declaring it,
18:01
Unidentified speaker (UNKNOWN): the
18:01
Unidentified speaker (speaker_0): conversation had moved
18:03
Unidentified speaker (UNKNOWN): on. If
18:04
Unidentified speaker (speaker_0): hunger could be rewritten, what else could?
18:08
Unidentified speaker (UNKNOWN): As
18:08
Unidentified speaker (speaker_0): Brian Johnson said, we might be the first generation that doesn't die.
18:26
Unidentified speaker (UNKNOWN): My
18:26
Unidentified speaker (speaker_3): teammate says he plays pickup basketball, quote, for the cardio. Well, there's more to it than that, Sean. Like with Bet365, I get paid the second my team goes up big with early payout and can cash out at any time before the game ends. Sean's getting his steps, but I'm getting paid. Bet365, the home of winning
18:46
Unidentified speaker (speaker_3): early. 18 plus, please play responsibly. Upper Up or to only terms, conditions, apply. If
18:49
Unidentified speaker (speaker_1): gambling is affecting your mental health or well, well-being, 211 Alberta is here to help. Call or text 211 or visit ab.211.ca. Standard message and data rates may apply.
18:56
Unidentified speaker (speaker_2): So your decaf oat milk, extra but not piping hot, four pumps of caramel, no sugar, small latte, and a large cup. That will be 10 minutes.
19:03
Unidentified speaker (speaker_3): No worries. I'm having fun on Playo.
19:06
Unidentified speaker (UNKNOWN): And
19:06
Unidentified speaker (speaker_3): I keep it fun with all the latest slot and live casino games. Plus, I get instant payouts with no minimum withdrawals. Oh, and no wagering requirements on. ever.
19:15
Unidentified speaker (speaker_2): Here's your decaf oat milk extra, but not piping hot.
19:17
Unidentified speaker (speaker_3): Ah, thanks. Playtime's over. Mmm, lovely.
19:21
Unidentified speaker (speaker_2): Feel the fun. Play O Joe.
19:23
Unidentified speaker (speaker_3): 18 plus Alberta only. Please play responsibly. Full term supply.
This page was produced automatically: the audio was transcribed with nvidia/parakeet-tdt-0.6b-v3+sortformer-v2.1 and interpreted by Qwen3.6-35B-A3B-UD-IQ3_S.gguf. Transcription and interpretation can contain errors; always confirm against the original episode. Nothing here is investment advice.

More from Crayon Capital

Crayon Capital

The Wolf of Wall Street Scam Explained Like You're 5

Episode discussion: Crayon Capital explores Jordan Belfort's rise and fall from penny stock broker to convicted felon.

Speakers’ claims: The episode details Jordan Belfort's early entrepreneurial ventures, including selling Italian ices and a failed meat delivery business, before his entry into the unregulated penny stock market following the 1987 Black Monday crash. Speakers describe how Belfort and partner Danny Porish founded Stratton Oakmont, a 'boiler room' firm that used high-pressure sales tactics and 'straight-line persuasion' to sell obscure stocks and manipulate IPOs. The narrative covers the SEC and FBI investigation led by agent Gregory Coleman, which resulted in the firm's raid in October 1996 and Belfort's subsequent cooperation with authorities. The speakers outline Belfort's legal consequences, including a 22-month prison sentence and a $110 million restitution order, while noting his continued career as a motivational speaker and author.

Penny StocksSecurities FraudBoiler Room
24 min0 assets10 claims to verify
Crayon Capital

Palantir Technologies Explained Like You’re 5

Episode discussion: Crayon Capital explores Palantir's evolution from CIA-funded intelligence tool to commercial enterprise platform.

Speakers’ claims: The episode details Palantir's origins in post-9/11 intelligence, funded by In-Q-Tel, and its initial military software 'Gotham'. Speakers describe the company's pivot to domestic surveillance, legal battles with the U.S. Army, and expansion into commercial markets via 'Foundry'. The narrative covers its 2020 direct listing, role in Ukraine, and development of predictive platforms like 'MetaConstellation'.

Palantir TechnologiesDefense TechnologyData Analytics
26 min0 assets9 claims to verify
All insights